Behavior Therapy for Irritability and Aggression in Adolescents With Autism

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This is a clinical trial of a novel intervention, Behavioral Therapy for Irritability and Aggression (BTIA), for adolescents on the autism spectrum. The main goals of BTIA are to help adolescents develop emotion regulation skills to handle frustration and to strengthen skills for navigating the challenging and diverse experiences associated with the transition to adulthood. The study will test whether BTIA can be helpful to adolescents on the autism spectrum and to their families.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 12
Maximum Age: 19
Healthy Volunteers: t
View:

• Boys and girls, ages 12 to 18 years inclusive

• Diagnosis of autism spectrum disorder

• Presence of disruptive behaviors such as irritability and anger outbursts

• No planned changes in the intensity of current treatment(s)

• Medication free or on stable medication

• Sufficient language for participation in verbal therapy

• Lives within driving distance from New Haven, CT

Locations
United States
Connecticut
Yale Child Study Center
RECRUITING
New Haven
Contact Information
Primary
Sydeny Anderson
sydney.anderson@yale.edu
(203) 737-7662
Time Frame
Start Date: 2020-12-10
Estimated Completion Date: 2026-02
Participants
Target number of participants: 126
Treatments
Experimental: Behavioral Therapy for Irritability in Autism (BTIA)
BTIA consists of 15 ninety-minute weekly sessions that will be conducted with the teens and their parents by experienced therapists using a structured, detailed manual.
Active_comparator: Psychoeducation and Supportive Therapy (PST)
PST consist of 15 weekly, ninety-minute sessions focused on learning about and discussing issues of diagnosis, treatment and educational services with an experienced therapist could be helpful to children on the autism spectrum and their families.
Sponsors
Leads: Yale University
Collaborators: Congressionally Directed Medical Research Programs

This content was sourced from clinicaltrials.gov